StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 747.00
-1.00 (-0.13%)
Oct 6, 2026, 3:30 PM JST
StemCell Institute Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,522 | 7,714 | 13,905 | 20,288 | 25,770 | 20,570 | |
Market Cap Growth | -19.94% | -44.52% | -31.46% | -21.27% | 25.28% | - |
Enterprise Value | 5,815 | 5,532 | 10,772 | 17,594 | 22,462 | 17,160 |
Last Close Price | 747.00 | 766.00 | 1357.00 | 1950.07 | 2476.99 | 1977.16 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 48.67 | 49.77 | 36.12 | 65.45 | 130.15 | 154.66 |
Forward PE | 51.97 | 39.49 | - | - | - | - |
PS Ratio | 2.68 | 2.74 | 5.19 | 8.18 | 12.32 | 11.55 |
PB Ratio | 2.45 | 2.51 | 5.29 | 7.54 | 11.21 | 9.78 |
P/TBV Ratio | 3.06 | 3.14 | 5.57 | 7.66 | 11.33 | 9.89 |
P/FCF Ratio | - | - | - | 134.36 | 599.30 | 71.42 |
P/OCF Ratio | 103.05 | 105.67 | 29.77 | 60.74 | 260.30 | 43.86 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.07 | 1.97 | 4.02 | 7.09 | 10.74 | 9.64 |
EV/EBITDA Ratio | 16.20 | 15.41 | 19.69 | 32.95 | 55.88 | 53.13 |
EV/EBIT Ratio | 28.65 | 27.25 | 25.71 | 42.50 | 75.38 | 75.60 |
EV/FCF Ratio | - | - | - | 116.52 | 522.37 | 59.58 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.15 | 0.15 | 0.20 | 0.00 | 0.00 | - |
Debt / EBITDA Ratio | 1.31 | 1.31 | 0.95 | 0.01 | 0.01 | - |
Debt / FCF Ratio | - | - | - | 0.05 | 0.12 | - |
Net Debt / Equity Ratio | -0.77 | -0.77 | -1.02 | -1.05 | -1.44 | -1.67 |
Net Debt / EBITDA Ratio | -6.58 | -6.58 | -4.90 | -5.31 | -8.26 | -10.87 |
Net Debt / FCF Ratio | 7.03 | 7.03 | 243.91 | -18.79 | -77.19 | -12.19 |
Asset Turnover | 0.36 | 0.36 | 0.38 | 0.40 | 0.38 | 0.39 |
Inventory Turnover | 21.14 | 21.14 | 21.46 | 22.35 | 19.11 | 18.61 |
Quick Ratio | 1.14 | 1.14 | 1.17 | 1.18 | 1.30 | 1.35 |
Current Ratio | 1.17 | 1.17 | 1.20 | 1.20 | 1.33 | 1.37 |
Return on Equity (ROE) | 4.59% | 4.59% | 14.48% | 12.43% | 9.00% | 7.77% |
Return on Assets (ROA) | 1.62% | 1.62% | 3.73% | 4.19% | 3.38% | 3.09% |
Return on Invested Capital (ROIC) | 20.58% | 37.31% | - | - | - | - |
Return on Capital Employed (ROCE) | 5.70% | 5.70% | 13.20% | 14.90% | 12.50% | 10.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.06% | 2.01% | 2.77% | 1.53% | 0.77% | 0.65% |
FCF Yield | -4.47% | -4.36% | -0.08% | 0.74% | 0.17% | 1.40% |
Payout Ratio | - | - | 66.23% | - | - | - |
Buyback Yield / Dilution | 1.39% | 1.39% | 0.05% | 0.00% | -102.33% | -4.05% |